NCT03644212View on ClinicalTrials.gov

Vitamin D Increases Serum Levels of the Soluble Receptor for Advanced Glycation End Products in Women With PCOS

PHASE4CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

October 31, 2013

Conditions
Polycystic Ovary SyndromeVitamin D Deficiency
Interventions
DRUG

Vitamin D3

Sixty-three vitamin D deficient women (16 with PCOS and 47 without PCOS) were supplemented with 50.000 IU of oral vitamin D3, once weekly for 8 weeks. Serum 25-hydroxyvitamin D (25OH-D), sRAGE and AMH levels were checked before and after treatment.

Trial Locations (1)

11219

Maimonides Medical Center, OBGYN clinic, Brooklyn

Sponsors
All Listed Sponsors
lead

Maimonides Medical Center

OTHER